Brief: Beroni Group Announces Submission Of Emergency Use Authorization To FDA For Covid-19 Rapid Test Detection Kit
26/03/2020 13:31
March 26 (Reuters) - Beroni Group Ltd BTG.NH :
* BERONI GROUP ANNOUNCES SUBMISSION OF EMERGENCY USE
AUTHORIZATION
TO US FDA FOR ITS COVID-19 RAPID TEST DETECTION KIT
Source text for Eikon: ID:nGNXfzpnJ
Further company coverage: BTG.NH
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beroni
See all newsBrief: Beroni Group’s Enhanced Covid-19 Antigen Rapid Test Kit Received CE Certification
Brief: Beroni Group Ltd Files For A U.S. IPO
Received Part Payment Of A $1.07 Mln Order For SARS-COV-2 Antigen Test Kit From A Japanese Pharma Co
Brief: Beroni Group Gets Approval For R&D Rebate From Australian Government
Brief: Beroni Group Says Study Of Its SARS-CoV-2 Antigen Test Kit Showed Overall Sensitivity Of 95%